05:04 AM EDT, 10/30/2024 (MT Newswires) -- Harmony Biosciences Holdings ( HRMY ) said late Tuesday that it launched an underwritten public offering of up to 8 million common shares by Marshman Fund Trust II and Valor IV Pharma Holdings.

The selling shareholders also plan to grant the underwriters a 30-day option to buy up to an additional 1.2 million shares of common stock.

The company said it is not offering any shares of common stock and will not receive any proceeds from the offering.

Price: 40.74, Change: -0.75, Percent Change: -1.81